Phosphoglucomutase 5 pseudogene 2 (PGM5P2)

Phosphoglucomutase 5 pseudogene 2 (PGM5P2) is a noncoding RNA annotated as a pseudogene. It does not code for a functional protein but is implicated in the regulation of biological processes relevant to cancer. Increased expression of PGM5P2 is correlated with better prognosis in certain cancers, such as lung adenocarcinoma and breast cancer, suggesting potential tumor-suppressive activities, including pro-apoptosis and antiangiogenesis. The precise molecular function and regulatory mechanisms of PGM5P2 remain unclear, and further research is required. While PGM5P2 may serve as a biomarker within prognostic gene signatures, it is not considered a classic therapeutic target like a receptor, enzyme, or transporter[1][2]. PGM5P2 is primarily referenced in molecular profiling studies, such as support vector machine (SVM) classifiers for disease prognosis, and has not been linked to direct pharmacological interventions or traditional therapeutic modalities[1][2].

Other names

AK096159